Details for New Drug Application (NDA): 018654
✉ Email this page to a colleague
NDA 018654 describes VERSED, which is a drug marketed by HLR and Roche and is included in two NDAs. Additional details are available on the VERSED profile page.
The generic ingredient in VERSED is midazolam hydrochloride. There are nine drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the midazolam hydrochloride profile page.
The generic ingredient in VERSED is midazolam hydrochloride. There are nine drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the midazolam hydrochloride profile page.
Summary for 018654
| Tradename: | VERSED |
| Applicant: | Hlr |
| Ingredient: | midazolam hydrochloride |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 018654
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 5MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Dec 20, 1985 | TE: | RLD: | Yes | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 1MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | May 26, 1987 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
